End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2 EUR | +1.11% |
|
-7.41% | -56.52% |
Jul. 03 | Phaxiam: EPIC Bpifrance exceeds 25% of share capital | CF |
Jun. 28 | Would you like some more inflation? | ![]() |
Business Summary
Number of employees: 68
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23-06-22 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23-06-22 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-22 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23-06-22 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23-06-22 |
General Counsel | - | 23-06-22 | |
Human Resources Officer | - | 23-06-22 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23-06-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-06-22 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23-06-22 |
Gil Beyen
BRD | Director/Board Member | 62 | 23-06-22 |
Martine George
BRD | Director/Board Member | 76 | 23-06-22 |
Director/Board Member | 66 | 23-06-22 | |
Didier Hoch
CHM | Chairman | 68 | 23-06-22 |
Leila Nicolas
BRD | Director/Board Member | - | 23-06-22 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23-06-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,137,712 | 10,660,161 ( 95.71 %) | 270 ( 0.002429 %) | 95.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
250 | 0.00% | 813 $ |
Company contact information
![address PHAXIAM Therapeutics S.A.(PHXM)](https://cdn.zonebourse.com/static/address/159356796.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.52% | 13.13M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- PHXM Stock
- Company PHAXIAM Therapeutics S.A.